What this quiz covers
This quiz focuses on Nutritional Needs And Nutrient Content, giving you a quick way to practice the rules, question types, and explanations that matter most for NAPLEX.
A 67-year-old man (weight 78 kg, height 172 cm) with chronic kidney disease stage 4 (estimated glomerular filtration rate 22 mL/min/1.73 m2) asks what to change in his diet to reduce complications. Medical history includes hypertension and type 2 diabetes; dietary preference is "meat-heavy," and he uses a salt substitute. Medications include lisinopril 20 mg daily, furosemide 40 mg daily, calcium acetate with meals, and a multivitamin. Labs: potassium 5.7 mEq/L (normal 3.5–5.0), phosphorus 5.8 mg/dL (normal 2.5–4.5), bicarbonate 19 mEq/L (normal 22–28), albumin 3.6 g/dL (normal 3.5–5.0). How should the patient's diet be adjusted to manage their condition?
NAPLEX Quiz
Practice Nutritional Needs And Nutrient Content in NAPLEX with focused quiz questions that help you check what you know, review explanations, and build confidence with test-style prompts.
This quiz focuses on Nutritional Needs And Nutrient Content, giving you a quick way to practice the rules, question types, and explanations that matter most for NAPLEX.
Try each quiz question before looking at the correct answer. Use the explanations to review missed ideas, then come back to similar questions until the pattern feels familiar.
A 67-year-old man (weight 78 kg, height 172 cm) with chronic kidney disease stage 4 (estimated glomerular filtration rate 22 mL/min/1.73 m2) asks what to change in his diet to reduce complications. Medical history includes hypertension and type 2 diabetes; dietary preference is "meat-heavy," and he uses a salt substitute. Medications include lisinopril 20 mg daily, furosemide 40 mg daily, calcium acetate with meals, and a multivitamin. Labs: potassium 5.7 mEq/L (normal 3.5–5.0), phosphorus 5.8 mg/dL (normal 2.5–4.5), bicarbonate 19 mEq/L (normal 22–28), albumin 3.6 g/dL (normal 3.5–5.0). How should the patient's diet be adjusted to manage their condition?
Explanation: This question tests dietary potassium management in advanced chronic kidney disease. The patient has CKD stage 4 with hyperkalemia (5.7 mEq/L) and uses potassium-based salt substitutes, creating cardiac arrhythmia risk. Limiting high-potassium foods and avoiding potassium-based salt substitutes is essential because failing kidneys cannot adequately excrete potassium, and the patient is on an ACE inhibitor (lisinopril) which further increases potassium. Increasing potassium intake (A) or continuing salt substitutes (B) would worsen hyperkalemia; increasing phosphorus (D) is contraindicated with already elevated levels (5.8 mg/dL). In CKD stage 4, dietary potassium should be limited to 2000-3000 mg/day, avoiding foods like bananas, oranges, potatoes, tomatoes, and salt substitutes containing potassium chloride.
A 28-year-old woman (weight 70 kg, height 165 cm) seeks weight-loss counseling. Medical history: prediabetes and hyperlipidemia; no renal or hepatic disease. Dietary preference: lactose intolerant; trying to avoid sugary beverages. Medications: atorvastatin 20 mg nightly and a combined oral contraceptive; no supplements. Labs: fasting glucose 108 mg/dL, A1c 5.9%, triglycerides 210 mg/dL, LDL 138 mg/dL, thyroid-stimulating hormone 2.1 mIU/L. She asks what nutrient balance change is most important to support weight loss while improving triglycerides. What dietary modification should be recommended?
Explanation: This question tests macronutrient balance for weight loss in prediabetes with hypertriglyceridemia. The key patient-specific factors are prediabetes with A1c 5.9%, elevated triglycerides at 210 mg/dL, lactose intolerance, and avoidance of sugary beverages. Reducing added sugars and refined carbohydrates while prioritizing high-fiber carbs and lean protein is the best choice to promote weight loss, improve insulin sensitivity, and lower triglycerides through better glycemic control. Increasing sugar-sweetened beverages risks hypoglycemia and contradicts goals; avoiding all fats ignores beneficial unsaturated fats for heart health; increasing saturated fats worsens triglycerides and insulin resistance. A transferable clinical pearl is that for hypertriglyceridemia >150 mg/dL, limit added sugars to <10% of calories and emphasize omega-3s. Use a decision framework: target 500–750 kcal/day deficit for 1–2 lb/week loss, balancing 45–65% carbs from high-fiber sources.
A 72-year-old woman (weight 52 kg, height 160 cm) is evaluated for poor appetite and unintentional weight loss over 3 months; she reports early satiety and fatigue. Medical history includes osteoarthritis and gastroesophageal reflux disease; she follows a low-salt diet and eats mostly toast, tea, and soup. Current medications include omeprazole 20 mg daily, acetaminophen as needed, and a daily multivitamin. Labs: hemoglobin 9.8 g/dL (normal 12–16), mean corpuscular volume 108 fL (normal 80–100), vitamin B12 140 pg/mL (normal 200–900), folate 9 ng/mL (normal 3–20), albumin 3.0 g/dL (normal 3.5–5.0). Which nutrient supplement is most appropriate for this patient?
Explanation: This question tests understanding of macrocytic anemia and vitamin B12 deficiency in elderly patients. The patient presents with macrocytic anemia (MCV 108 fL), low vitamin B12 (140 pg/mL), and risk factors including advanced age, chronic PPI use (omeprazole), and poor dietary intake. Cyanocobalamin 1000 mcg daily is the best choice because it directly addresses the documented B12 deficiency causing her macrocytic anemia and associated symptoms. Folic acid (A) is incorrect as folate levels are normal (9 ng/mL); ferrous sulfate (C) treats microcytic, not macrocytic anemia; vitamin D3 (D) doesn't address the anemia. Long-term PPI use impairs B12 absorption by reducing gastric acid needed to release B12 from food proteins, making oral high-dose supplementation necessary to overcome malabsorption through passive diffusion.
An 80-year-old man (weight 60 kg, height 178 cm) living alone presents for a medication review and reports fatigue and decreased appetite; he has difficulty chewing due to poor dentition. Medical history includes chronic obstructive pulmonary disease and depression; diet is limited to soft foods and he often skips meals. Medications include sertraline 50 mg daily, tiotropium inhaler daily, and a calcium/vitamin D supplement. Labs: albumin 2.9 g/dL (normal 3.5–5.0), prealbumin 12 mg/dL (normal 16–35), sodium 138 mEq/L (normal 135–145), creatinine 0.9 mg/dL (normal 0.6–1.3). Which nutritional parameter should be monitored to assess response to nutrition interventions over the next 1–2 weeks?
Explanation: This question tests knowledge of nutritional assessment markers in elderly patients with malnutrition. The patient shows signs of protein-energy malnutrition with low albumin (2.9 g/dL) and prealbumin (12 mg/dL), requiring monitoring of intervention effectiveness. Prealbumin is the best choice because its half-life of 2-3 days makes it responsive to short-term nutritional changes, allowing assessment within 1-2 weeks. Height (B) doesn't change with nutrition interventions; LDL cholesterol (C) and hemoglobin A1c (D) reflect longer-term changes and aren't primary malnutrition markers. Prealbumin (transthyretin) increases within days of adequate protein/calorie intake, making it ideal for monitoring acute nutritional rehabilitation, though it can be falsely elevated in renal dysfunction or decreased in inflammation.
A 66-year-old woman (weight 82 kg, height 165 cm) with heart failure with reduced ejection fraction presents for nutrition counseling due to edema and frequent hospitalizations. Dietary restriction: trying to follow a low-sodium diet but eats canned soups and deli meats daily. Medications: sacubitril/valsartan, carvedilol, spironolactone, and furosemide. Labs: sodium 134 mEq/L (normal 135–145), potassium 5.1 mEq/L (normal 3.5–5.0), creatinine 1.3 mg/dL. What dietary modification should be recommended?
Explanation: This question tests sodium restriction in heart failure to manage edema and hospitalizations. The key patient-specific factors are heart failure with reduced ejection fraction, edema, frequent hospitalizations, high-sodium intake from canned soups/deli meats, and hyponatremia at 134 mEq/L. Limiting sodium by avoiding processed foods and targeting 2,000 mg/day is the best choice to reduce fluid retention and improve symptoms without worsening hyponatremia. Increasing sodium to 4,000 mg/day risks fluid overload; potassium salt substitutes could elevate potassium (already 5.1 mEq/L); increasing fluids >3 L/day exacerbates edema. A transferable clinical pearl is that in heart failure, restrict sodium to 2,000–3,000 mg/day, monitoring for hyponatremia. Use a decision framework: assess sodium labs and diet history, then educate on label reading and alternatives like herbs.
A 76-year-old man (weight 60 kg, height 178 cm) living alone presents for nutritional assessment after a recent hospitalization for pneumonia. He reports early satiety and eating only one small meal per day; he prefers a low-salt diet. Medications: sertraline 50 mg daily, omeprazole 20 mg daily, and furosemide 20 mg daily; no supplements. Labs: albumin 2.7 g/dL (normal 3.5–5.0), prealbumin 12 mg/dL (normal 16–35), potassium 3.4 mEq/L (normal 3.5–5.0). What is the best recommendation for managing this patient's nutrient intake?
Explanation: This question tests nutritional strategies for malnutrition in elderly patients with early satiety. The key patient-specific factors are a 76-year-old with recent pneumonia, early satiety, one small meal/day, low albumin (2.7 g/dL), and prealbumin (12 mg/dL) indicating malnutrition. Encouraging small, frequent, energy-dense meals and oral nutrition supplements is the best choice to boost calorie and protein intake, combat weight loss, and improve albumin without overwhelming appetite. Restricting protein to 0.4 g/kg/day worsens malnutrition; avoiding all fats ignores their caloric density for energy; increasing fluids to 4–5 L/day risks hyponatremia and doesn't stimulate appetite. A transferable clinical pearl is that in geriatric malnutrition, aim for 1.2–1.5 g/kg protein and 30–35 kcal/kg daily via modular supplements. Use a decision framework: screen with albumin/prealbumin, then prioritize nutrient-dense options for satiety issues.
A 57-year-old woman (weight 73 kg, height 167 cm) with stage 5 chronic kidney disease on hemodialysis is receiving counseling on protein intake. Dietary preference: enjoys salads and fruit; limits salt. Medications: epoetin alfa, sevelamer, and a renal multivitamin. Labs: albumin 3.0 g/dL (normal 3.5–5.0), phosphorus 5.9 mg/dL, potassium 5.2 mEq/L. What is the best recommendation for managing this patient's nutrient intake?
Explanation: This question tests protein optimization in end-stage renal disease on dialysis. The key patient-specific factors are stage 5 CKD on hemodialysis, low albumin (3.0 g/dL) indicating malnutrition, hyperphosphatemia (5.9 mg/dL), and enjoyment of salads/fruit. Increasing high-quality protein to ~1.2 g/kg/day while controlling phosphorus with binders is the best choice to improve albumin and muscle mass without elevating phosphorus. Restricting to 0.3 g/kg/day worsens malnutrition; eliminating protein ignores needs; increasing potassium fruits risks hyperkalemia. A transferable clinical pearl is that dialysis patients need 1.2–1.4 g/kg protein, half from high-biological value sources. Use a decision framework: assess albumin <3.5 g/dL, calculate needs (e.g., 73 kg x 1.2 = 88 g/day), and integrate binders.
A 68-year-old man (weight 72 kg, height 170 cm) with atrial fibrillation on warfarin presents for counseling after starting a "greens powder" supplement. Diet: tries to eat healthier and increase leafy greens; no other restrictions. Medications: warfarin and metoprolol. Labs: international normalized ratio 2.6 (goal 2.0–3.0). What is the most important counseling point for this dietary supplement?
Explanation: This question tests managing vitamin K-warfarin interactions with consistent intake. The key patient-specific factors are atrial fibrillation on warfarin, starting greens powder (high vitamin K), increasing leafy greens, and stable INR at 2.6. Maintaining consistent vitamin K intake and notifying the clinic before changes is the best choice to prevent INR fluctuations. Avoiding all vitamin K destabilizes INR; taking only on skipped warfarin days risks inconsistency; increasing to INR >4.0 risks bleeding. A transferable clinical pearl is that consistent 90–120 mcg vitamin K/day stabilizes warfarin; adjust dose, not diet. Use a decision framework: educate on consistency, monitor INR weekly with changes, and list high-K foods.
A 39-year-old man (weight 80 kg, height 182 cm) with ulcerative colitis reports fatigue and shortness of breath on exertion. Diet: omnivorous; no restrictions. Medications: mesalamine and prednisone taper. Labs: hemoglobin 9.9 g/dL, ferritin 10 ng/mL (normal 12–200), transferrin saturation 12% (normal 20–50). Which nutrient supplement is most appropriate for this patient?
Explanation: This question tests iron supplementation in inflammatory bowel disease with anemia. The key patient-specific factors are ulcerative colitis, fatigue/shortness of breath, low hemoglobin (9.9 g/dL), ferritin (10 ng/mL), and transferrin saturation (12%) indicating iron deficiency anemia. Oral elemental iron 65 mg every other day is the best choice as it corrects deficiency with better tolerability and absorption in alternate dosing. Calcium doesn't treat anemia; vitamin B12 is for megaloblastic, not low ferritin; vitamin D isn't primary for hemoglobin. A transferable clinical pearl is that alternate-day iron maximizes absorption by avoiding hepcidin surge; target 50–100 mg elemental/day. Use a decision framework: confirm iron deficiency with ferritin <30 ng/mL in inflammation, start oral if tolerated, recheck in 4 weeks.
A 61-year-old man (weight 88 kg, height 176 cm) with type 2 diabetes and chronic kidney disease stage 4 is receiving counseling on meal planning. Dietary restriction: low-potassium and low-phosphorus diet; he likes dairy and beans. Medications: insulin glargine, insulin aspart, sevelamer with meals, and amlodipine. Labs: potassium 5.5 mEq/L, phosphorus 6.0 mg/dL, albumin 3.2 g/dL. How should the patient's diet be adjusted to manage their condition?
Explanation: This question tests phosphorus management in CKD with diabetes. The key patient-specific factors are stage 4 CKD, type 2 diabetes, hyperphosphatemia at 6.0 mg/dL, hyperkalemia at 5.5 mEq/L, low albumin, and preference for high-phosphorus foods like dairy and beans. Choosing lower-phosphorus proteins and limiting high-phosphorus foods while maintaining calories is the best choice to control phosphorus, support nutrition, and prevent complications like bone disease. Increasing dairy worsens phosphorus; increasing oranges/potatoes elevates potassium; eliminating carbs ignores diabetes needs. A transferable clinical pearl is that in CKD, limit phosphorus to 800–1,000 mg/day using binders and low sources like egg whites. Use a decision framework: check phosphorus >4.5 mg/dL, adjust diet/bindings, and ensure 0.6–0.8 g/kg protein pre-dialysis.
A 45-year-old woman (weight 68 kg, height 162 cm) with celiac disease presents with fatigue and numbness/tingling in her feet. Dietary restriction: gluten-free; she reports inconsistent adherence. Medications: none; supplements: none. Labs: hemoglobin 10.6 g/dL, mean corpuscular volume 112 fL, vitamin B12 160 pg/mL (normal 200–900), folate 9 ng/mL (normal 3–17). Which nutrient supplement is most appropriate for this patient?
Explanation: This question tests the identification of vitamin B12 deficiency in malabsorptive conditions like celiac disease. The key patient-specific factors are celiac disease with inconsistent gluten-free adherence, macrocytic anemia (hemoglobin 10.6 g/dL, MCV 112 fL), low B12 at 160 pg/mL, and neuropathy symptoms. Cyanocobalamin (vitamin B12) 1,000 mcg orally daily is the best choice as it corrects deficiency due to ileal malabsorption in celiac, improving anemia and neuropathy. Folic acid 1 mg daily is suboptimal without low folate (9 ng/mL is normal); ferrous gluconate addresses iron deficiency, not macrocytic features; vitamin C 1,000 mg daily enhances iron absorption but ignores B12. A transferable clinical pearl is that B12 deficiency often presents with neuropathy in malabsorption; supplement 1,000 mcg daily orally for mild cases. Use a decision framework: check MCV and B12/folate levels in anemia, prioritizing B12 if <200 pg/mL in at-risk patients.
A 52-year-old man (weight 85 kg, height 180 cm) with alcohol use disorder presents with confusion and unsteady gait. Dietary history: poor intake for weeks; no specific dietary restrictions. Medications: none. Labs: magnesium 1.4 mg/dL (normal 1.7–2.2), albumin 2.8 g/dL, glucose 96 mg/dL. The team plans to start dextrose-containing IV fluids. Which nutrient supplement is most appropriate for this patient?
Explanation: This question tests prevention of Wernicke encephalopathy in alcohol use disorder with thiamine supplementation. The key patient-specific factors are alcohol use disorder, confusion, unsteady gait (suggesting Wernicke), poor intake, and planned glucose IV fluids. Thiamine (vitamin B1) 100 mg before glucose administration is the best choice to prevent encephalopathy by replenishing depleted stores in alcoholics before glucose exacerbates it. Niacin 500 mg daily addresses pellagra, not acute risk; pyridoxine 200 mg daily is for other deficiencies; vitamin K1 10 mg daily corrects coagulopathy, not neurologic issues. A transferable clinical pearl is that thiamine deficiency is common in alcoholism; give 100–500 mg IV/IM before glucose in suspected cases. Use a decision framework: suspect Wernicke with ataxia/confusion, prioritize thiamine, then address other electrolytes like magnesium.
A 70-year-old woman (weight 58 kg, height 158 cm) with a history of hip fracture presents for osteoporosis prevention counseling. Dietary restriction: lactose intolerant; low dairy intake. Medications: alendronate weekly and pantoprazole daily. Labs: 25-hydroxyvitamin D 26 ng/mL (normal 20–50), serum calcium 9.1 mg/dL. She asks which calcium supplement is best given chronic proton pump inhibitor use. Which nutrient supplement is most appropriate for this patient?
Explanation: This question tests optimal calcium supplementation in patients on proton pump inhibitors (PPIs) with osteoporosis risk. The key patient-specific factors are osteoporosis history, lactose intolerance with low dairy, chronic PPI use reducing acid-dependent absorption, and normal calcium/vitamin D labs. Calcium citrate 500 mg elemental twice daily is the best choice as it's acid-independent, better absorbed on PPIs, and split doses enhance uptake. Calcium carbonate requires acid and empty stomach is suboptimal; magnesium oxide isn't primary for bone; zinc doesn't replace calcium. A transferable clinical pearl is that citrate forms are preferred on PPIs or in achlorhydria; aim for 1,000–1,200 mg elemental calcium/day. Use a decision framework: assess absorption barriers, choose citrate if needed, and pair with vitamin D.
A 34-year-old woman (weight 62 kg, height 170 cm) who is 10 weeks pregnant requests advice for nausea and wants to start a supplement. Dietary preference: vegetarian. Medications: prenatal vitamin (contains folic acid 800 mcg and iron 27 mg). Labs: hemoglobin 12.1 g/dL, vitamin B6 level not available. She asks about vitamin B6 dosing for pregnancy-related nausea. What is the most important counseling point for this dietary supplement?
Explanation: This question tests safe vitamin B6 dosing for pregnancy-related nausea. The key patient-specific factors are 10 weeks pregnant with nausea, vegetarian diet, and taking a prenatal vitamin. Pyridoxine (vitamin B6) 10–25 mg orally three times daily is the best choice as it's safe and effective for nausea, with caution against high chronic doses due to neuropathy risk. 500 mg three times daily exceeds safe limits and risks toxicity; avoiding B6 is incorrect as it's recommended; vitamin A 25,000 IU daily risks teratogenicity. A transferable clinical pearl is that vitamin B6 up to 100 mg/day is safe in pregnancy for nausea per ACOG. Use a decision framework: start at low doses, monitor symptoms, and avoid >200 mg/day long-term to prevent sensory neuropathy.
A 62-year-old man (weight 90 kg, height 175 cm) with type 2 diabetes asks about adjusting his diet for better glycemic control. Diet: typically eats large portions of rice and noodles; no food allergies. Medications: metformin 1,000 mg twice daily and empagliflozin 25 mg daily. Labs: A1c 7.9%, fasting glucose 148 mg/dL, triglycerides 160 mg/dL. How should the patient's diet be adjusted to manage their condition?
Explanation: This question tests carbohydrate distribution for glycemic control in type 2 diabetes. The key patient-specific factors are type 2 diabetes with A1c 7.9%, large portions of refined starches like rice/noodles elevating glucose. Distributing carbohydrates consistently across meals and reducing refined portions while increasing nonstarchy vegetables is the best choice to stabilize glucose and improve A1c without extremes. Consuming all carbs in one meal spikes glucose; avoiding vegetables removes fiber benefits; increasing juice adds simple sugars. A transferable clinical pearl is that consistent carb intake (45–60 g/meal) minimizes variability; use plate method for balance. Use a decision framework: review A1c/glucose, educate on portion control, and monitor with logs.
A 30-year-old woman (weight 64 kg, height 168 cm) presents with diffuse bone pain and proximal muscle weakness. Medical history: long-term anticonvulsant therapy for epilepsy. Dietary preference: avoids dairy. Medications: phenytoin and a multivitamin taken inconsistently. Labs: 25-hydroxyvitamin D 9 ng/mL (normal 20–50), calcium 8.2 mg/dL (normal 8.5–10.5), alkaline phosphatase elevated. Which nutrient supplement is most appropriate for this patient?
Explanation: This question tests treatment of severe vitamin D deficiency in patients on enzyme-inducing anticonvulsants. The key patient-specific factors are long-term phenytoin use accelerating vitamin D metabolism, severe deficiency (9 ng/mL), hypocalcemia, elevated ALP, bone pain, and dairy avoidance. Cholecalciferol 50,000 IU weekly for 8 weeks then maintenance is the best choice for rapid repletion in severe deficiency (<10 ng/mL). 400 IU daily is insufficient for repletion; vitamin A risks toxicity; vitamin E doesn't correct deficiency. A transferable clinical pearl is that anticonvulsants like phenytoin require higher vitamin D doses; replete with 50,000 IU weekly if <20 ng/mL. Use a decision framework: check 25-OH D, replete aggressively if <12 ng/mL, then maintain 1,000–2,000 IU daily.
A 69-year-old woman (weight 65 kg, height 162 cm) with type 2 diabetes and peripheral neuropathy asks which nutritional parameter should be monitored due to long-term metformin use. Diet: balanced; no restrictions. Medications: metformin 1,000 mg twice daily for 8 years and gabapentin. Labs: A1c 7.2%, creatinine 0.8 mg/dL, hemoglobin 12.0 g/dL, mean corpuscular volume 101 fL. Which nutritional parameter should be monitored?
Explanation: This question tests knowledge of nutrient deficiencies associated with long-term metformin therapy in patients with type 2 diabetes. The key patient-specific factors include 8 years of metformin use, peripheral neuropathy, mildly low hemoglobin, and elevated mean corpuscular volume (MCV) suggestive of macrocytic anemia. Serum vitamin B12 level should be monitored because metformin impairs vitamin B12 absorption in the ileum, potentially leading to deficiency that manifests as neuropathy and macrocytic anemia, aligning with this patient's presentation. Serum vitamin K level is incorrect as metformin does not affect vitamin K absorption or levels, and there is no associated deficiency risk. Serum vitamin A level is suboptimal as metformin has no established link to vitamin A deficiency; similarly, serum sodium level is not the primary metformin-related nutrient risk, though rare electrolyte imbalances can occur but are not the main concern here. A clinical pearl is that routine monitoring of vitamin B12 is recommended for patients on metformin for over 4 years, particularly those with risk factors like older age or neuropathy. This underscores the importance of assessing medication-induced nutritional deficiencies to prevent complications like irreversible nerve damage.
A 64-year-old man (weight 78 kg, height 172 cm) with stage 4 chronic kidney disease (estimated glomerular filtration rate 22 mL/min/1.73 m2) and hypertension is referred for renal diet counseling. Dietary preference: enjoys bananas and orange juice daily; trying to limit salt. Medications: lisinopril 10 mg daily, furosemide 40 mg daily, calcium acetate with meals, and a renal multivitamin. Labs: potassium 5.8 mEq/L (normal 3.5–5.0), phosphorus 5.6 mg/dL (normal 2.5–4.5), albumin 3.4 g/dL, bicarbonate 20 mEq/L (normal 22–29). What dietary modification should be recommended?
Explanation: This question tests dietary management of hyperkalemia in chronic kidney disease (CKD). The key patient-specific factors are stage 4 CKD with eGFR 22 mL/min/1.73 m², hyperkalemia at 5.8 mEq/L, and daily consumption of high-potassium foods like bananas and orange juice. Limiting high-potassium foods such as bananas and orange juice while choosing lower-potassium fruits is the best choice to reduce serum potassium and prevent arrhythmias without compromising nutrition. Increasing bananas and orange juice would worsen hyperkalemia and is incorrect; increasing dietary phosphorus via dairy is suboptimal as phosphorus is already elevated; raising protein to 1.5 g/kg/day exceeds CKD guidelines and could accelerate progression. A transferable clinical pearl is that in CKD stages 3–5, restrict potassium to 2,000–3,000 mg/day by leaching vegetables and avoiding high sources. Use a decision framework: assess labs first, then tailor restrictions to potassium >5.0 mEq/L while ensuring adequate calories and protein.
A 3-year-old boy (weight 12.2 kg, height 89 cm) is brought in for poor growth and irritability. He drinks about 32 ounces of cow's milk daily and is a picky eater; no known food allergies. Medications include none; supplements include an occasional gummy multivitamin. Labs: hemoglobin 10.2 g/dL (normal 11.5–13.5), mean corpuscular volume 72 fL (normal 75–87), ferritin 8 ng/mL (normal 12–200), lead level normal, albumin 4.0 g/dL (normal 3.5–5.0). What is the best recommendation for managing this patient's nutrient intake?
Explanation: This question evaluates iron deficiency anemia management in toddlers with excessive milk consumption. The child has microcytic anemia (MCV 72 fL) with low ferritin (8 ng/mL), classic for iron deficiency from excessive cow's milk intake displacing iron-rich foods. Starting ferrous sulfate at 3 mg/kg/day elemental iron and reducing milk to 16-24 ounces daily is correct because it provides therapeutic iron dosing while limiting milk to allow appetite for iron-containing foods. Vitamin B12 (B) doesn't address iron deficiency; calcium supplementation (C) with increased milk would worsen iron absorption; folic acid (D) treats megaloblastic, not microcytic anemia. Excessive milk intake (>24 oz/day) causes iron deficiency through poor iron bioavailability in milk, displacement of iron-rich foods, and potential occult GI blood loss from milk protein-induced enteropathy.
A 62-year-old woman (weight 70 kg, height 165 cm) with hypertension and heart failure with reduced ejection fraction is counseled on diet after reporting ankle swelling. She prefers canned soups and deli meats because of convenience and states she is "already on a low-salt diet." Medications include sacubitril/valsartan, carvedilol, furosemide, and potassium chloride 20 mEq daily. Labs: sodium 134 mEq/L (normal 135–145), potassium 4.2 mEq/L (normal 3.5–5.0), serum creatinine 1.1 mg/dL (normal 0.6–1.3). What dietary modification should be recommended?
Explanation: This question evaluates sodium restriction in heart failure management. The patient has heart failure with ankle edema despite claiming a "low-salt diet," but prefers high-sodium foods (canned soups, deli meats). Limiting sodium to ≤2000 mg/day by choosing low-sodium products and avoiding processed meats is correct because sodium restriction reduces fluid retention and improves heart failure outcomes. Increasing processed foods (A) worsens sodium intake; potassium-based substitutes (C) are risky with sacubitril/valsartan which can increase potassium; excessive fluid intake (D) worsens volume overload. Canned soups and deli meats often contain 800-1500 mg sodium per serving; teaching label reading and suggesting fresh/frozen alternatives helps achieve true sodium restriction in heart failure management.